TAPI offers customized CDMO Solutions for API development and manufacturing services.
01 1Teva API India Private Ltd
02 1Aurobindo Pharma Limited
03 1Azico Biophore India Private Limited
04 1Maithri Drugs Private Limited
05 1Professional Compounding Centers of America dba PCCA
01 5Docosanol
01 3India
02 1Israel
03 1United Kingdom
TAPI offers customized CDMO Solutions for API development and manufacturing services.
NDC Package Code : 15894-0036
Start Marketing Date : 2020-10-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-490
Start Marketing Date : 2024-01-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69575-4024
Start Marketing Date : 2017-12-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 70600-010
Start Marketing Date : 2018-09-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-5068
Start Marketing Date : 2019-08-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Abreva manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Abreva, including repackagers and relabelers. The FDA regulates Abreva manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Abreva API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Abreva manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Abreva supplier is an individual or a company that provides Abreva active pharmaceutical ingredient (API) or Abreva finished formulations upon request. The Abreva suppliers may include Abreva API manufacturers, exporters, distributors and traders.
click here to find a list of Abreva suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Abreva as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Abreva API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Abreva as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Abreva and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Abreva NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Abreva suppliers with NDC on PharmaCompass.
We have 5 companies offering Abreva
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
